Investors & Dealmaking
PwC Sees Momentum Building for More Medtech Deals in 2026
After a few up-and-down years, PwC analysts expect the medtech industry’s appetite for mergers and acquisitions will return to historical averages as the large strategics are transforming their portfolios in search of faster growth and technological transformation.
Read Article